Welltower Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 3/6
Welltower verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 28.1%, während die Gewinne der Branche Health Care REITs jährlich um gewachsen und zwar um 17.3%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 19.1%. Die Eigenkapitalrendite von Welltower beträgt 3.2% und die Nettomargen betragen 12%.
Wichtige Informationen
28.12%
Wachstumsrate der Gewinne
15.03%
EPS-Wachstumsrate
| Health Care REITs Wachstum der Industrie | -12.20% |
| Wachstumsrate der Einnahmen | 19.15% |
| Eigenkapitalrendite | 3.24% |
| Netto-Marge | 11.96% |
| Letzte Ertragsaktualisierung | 31 Mar 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Narrativ-Update • May 14
WELL: Data Science Partnership And 2026 Earnings Outlook Will Support Balanced View
Analysts have raised their price target for Welltower to $233.50 from $229.25, citing updated assumptions related to revenue growth, profit margins, the discount rate, and future P/E levels. What's in the News Welltower updated its earnings guidance for the year ending December 31, 2026, with net income attributable to common stockholders now guided to a range of $3.24 to $3.38 per diluted share, compared with the prior range of $3.11 to $3.27 (company guidance).Seeking Alpha • May 01
Welltower: A Premium REIT At An Overextended Price
Summary Welltower Inc. is a top-tier REIT with strong fundamentals, robust FFO growth, and disciplined capital allocation. WELL's SHO segment drove Q1'26 FFO up 23% YoY, with same-store NOI growth of 22.1% and occupancy at 88.8%. Despite operational excellence, WELL trades at a 33x P/FFO—over 30% above its historical average and 131% above peers, making current valuation difficult to justify. I rate WELL a 'sell' at $217, with a more attractive entry in the $155–$165 range when valuation better reflects premium quality. Read the full article on Seeking AlphaNarrativ-Update • Apr 29
WELL: Data Science Partnership And 2026 Guidance Will Support Balanced Outlook
Analysts have made a small adjustment to Welltower's price target to $229.25. This reflects updated views on fair value, discount rate assumptions, profit margin expectations, and a revised future P/E estimate.
Narrativ-Update • Apr 14
WELL: Data Partnership And Higher Margins Will Support Future Upside Potential
Analysts now see Welltower's fair value at $260.00, compared with $251.51 previously. This reflects their updated views on growth, margins, discount rate and future P/E assumptions.Narrativ-Update • Mar 31
WELL: Data Science Alliance And 2026 Earnings Outlook Will Support Future Upside
Analysts have raised their price target for Welltower from $228.10 to $229.30, reflecting updated assumptions related to discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News Welltower and Public Storage announced a data science partnership that combines Welltower's capital allocation models with Public Storage's operational and pricing analytics to support more targeted real estate investments and operations (Key Developments).Narrativ-Update • Mar 17
WELL: 2026 Earnings Outlook And Data Partnership Will Shape Future Income
Analysts have raised their price target on Welltower to $228.10 from $218.80, reflecting updated assumptions that include a slightly lower discount rate, a modest adjustment to revenue growth expectations, firmer profit margin inputs near 14%, and a higher future P/E of about 98x. What's in the News Welltower and Public Storage announced a data science partnership that combines Welltower's capital allocation modeling with Public Storage's operational analytics to support capital deployment and operating decisions across both businesses (Key Developments).
Neues Narrativ • Mar 16
Leveraging the Senior Housing Supply Gap
Business Overview Welltower is one of the largest healthcare real estate investment trusts globally, with a market capitalization of approximately US$145 billion. The company owns a diversified portfolio of senior housing communities, outpatient medical facilities and post-acute care properties across the United States, Canada and the United Kingdom.
Narrativ-Update • Mar 03
WELL: Medium Term Guidance And Updated Assumptions Will Shape Fair Value
Analysts have lifted their price target for Welltower from about $145 to roughly $191, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, which together support a higher long term valuation framework. What's in the News Welltower issued earnings guidance for the year ending December 31, 2026, giving investors a frame of reference for its medium term outlook.Narrativ-Update • Feb 16
WELL: 2026 Earnings Outlook And Higher Fair Value Will Shape Future Income
Analysts now set their price target for Welltower at $218.80, up from $207.38. This reflects updated views on revenue growth, profit margins and future P/E assumptions.Narrativ-Update • Feb 02
WELL: Higher Profitability Assumptions Will Support Future Upside Potential
Analysts have raised their fair value estimate for Welltower to $251.51, citing slightly higher assumptions for revenue growth, profit margins, the discount rate, and future P/E as the basis for the updated price target. Valuation Changes Fair Value Estimate was adjusted from $248.75 to $251.51, reflecting a small upward revision in the modeled valuation.Narrativ-Update • Jan 19
WELL: Expanded Equity Will Fund Prospective UK Care Acquisition Opportunity
Analysts have inched their price target for Welltower lower by about US$0.05. This reflects small updates to their fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Narrativ-Update • Jan 05
WELL: Expanded Equity Capacity Will Support Prospective UK Senior Care Acquisition
Analysts have nudged their price target on Welltower slightly lower to US$248.80 from US$250.84, citing updated assumptions around revenue growth, profit margins, and a higher future P/E multiple. What's in the News Welltower filed a follow on equity offering for up to US$7.5b in common stock, structured as an at the market program.Narrativ-Update • Dec 18
WELL: Expanded Equity Capacity Will Support Prospective UK Senior Care Acquisition
Analysts have lifted their price target on Welltower materially, from approximately $208 to $251 per share, citing expectations for slightly faster revenue growth, stronger profit margins, and a modestly lower future P/E multiple despite a higher discount rate. What's in the News Filed a new at-the-market follow-on equity shelf for up to $7.5 billion of common stock, expanding financial flexibility for future investments and debt reduction (regulatory filing).Narrativ-Update • Dec 04
WELL: Equity Issuance And Acquisition Plans Will Shape Future Income Outlook
Analysts have raised their price target for Welltower by approximately $8.40 per share to about $207.40. This reflects expectations for stronger revenue growth that more than offset a modestly lower profit margin outlook and a slightly higher assumed valuation multiple.Narrativ-Update • Nov 20
WELL: Equity Offerings And Margin Improvement Will Offset Lower Income Outlook
Analysts have raised their price target for Welltower from $192.90 to $198.95, citing improved profit margins and a modestly higher discount rate in their latest assessment. What's in the News Welltower has filed a Follow-on Equity Offering totaling $7.5 billion, issuing common stock through an at-the-market offering.Narrativ-Update • Nov 05
WELL: Forward Equity Offerings And Margin Gains Will Balance Lower Guidance
Analysts have raised their price target for Welltower from $187.43 to $192.90. They cite improved profit margins and a lowered discount rate, even though revenue growth expectations are moderating.Narrativ-Update • Oct 22
Analysts Lift Welltower Price Target Amid Raised Guidance and Improved Valuation Metrics
Analysts have slightly raised their price target for Welltower. They now estimate fair value at $187.43 per share, compared to the previous $186.81, citing incremental improvements in key valuation metrics.Narrativ-Update • Oct 08
Private Fund Management And Acquisitions Will Improve Operational Efficiency
Analysts have raised their price target for Welltower to $186.81 from $184.60, reflecting modest improvements in projected fair value and slightly lower discount rate assumptions. What's in the News On July 28, 2025, Welltower's Board of Directors declared a quarterly cash dividend of $0.74 per share.Narrativ-Update • Sep 24
Private Fund Management And Acquisitions Will Improve Operational Efficiency
Welltower’s consensus price target increased as improved net profit margin and a modestly lower future P/E signal incremental enhancements in profitability and valuation, lifting fair value from $180.37 to $184.60. What's in the News Welltower did not repurchase any shares in the latest buyback tranche, completing 0% of the previously announced buyback program.Narrativ-Update • Sep 04
Private Fund Management And Acquisitions Will Improve Operational Efficiency
With analyst reasoning unavailable and both revenue growth and discount rate estimates unchanged, the consensus analyst price target for Welltower remained steady at $178.47. What's in the News Welltower repurchased 0 shares for $0 million from April 1, 2025 to June 30, 2025, completing 0% of the buyback announced earlier.Seeking Alpha • Feb 19
Welltower Stock: Long-Term Potential Vs. Near-Term Risks
Summary Welltower has shown impressive operational performance, particularly in its senior housing segment, but its current valuation suggests waiting for a better entry point. WELL benefits from favorable demographics and strong growth in senior housing, with significant occupancy gains and margin expansion driving its success. Despite strong financial metrics and a robust balance sheet, Welltower’s stock price appears overvalued, trading at a high multiple compared to sector averages. Long-term growth prospects remain strong, but the current price leaves little margin of safety, making it prudent to wait for a more attractive entry point. Read the full article on Seeking AlphaSeeking Alpha • Dec 01
Welltower REIT Became Too Pricey
Summary Welltower Inc. has shown strong financial performance, driven by impressive growth in its senior housing operating portfolio (SHOP) and strategic acquisitions. The company has successfully deleveraged its balance sheet, maintaining significant liquidity and funding acquisitions, while enhancing its operating system and paying dividends. Despite strong growth and favorable demographic trends, WELL's stock appears overvalued, with a premium price and lower-than-historical dividend yield. Given the current valuation, I recommend a "Hold" rating, suggesting the stock needs to drop about 20% to become a "Buy" again. Read the full article on Seeking AlphaSeeking Alpha • Nov 16
Welltower: Senior Housing Isn't A Growth Stock
Summary Welltower, Inc. is a REIT focused on senior housing and medical properties, benefiting from an aging population but currently offering a modest 2% dividend yield. The company's dividend has declined from $3.48 per share (2017-2019) to $2.44 in 2023, despite revenue recovery post-COVID. Concerns include low property yields, leverage risks, and reliance on private-pay residents, which may not support long-term dividend growth. Given these issues and the lack of a compelling margin of safety, I rate WELL as a Hold. Read the full article on Seeking AlphaSeeking Alpha • Sep 02
Welltower: Aging Gracefully Or Out Of Touch? Stock That's Priced For Perfection
Summary Welltower Inc. has seen a 49% stock increase and a steady 2% dividend over the past year, outperforming the REIT sector significantly. Despite favorable demographic trends and a solid portfolio, Welltower's AFFO growth per share has been lackluster, raising concerns about future dividend growth. The company's current valuation appears high, with a forward P/AFFO and P/FFO well above sector medians, suggesting limited upside potential. Given the high valuation and modest AFFO growth, I rate Welltower as a 'sell' despite its positive long-term industry tailwinds. Read the full article on Seeking Alpha
Neues Narrativ • Aug 20
Decisive Acquisitions And Operational Efficiencies Propel Senior Housing Leader To New Heights
Welltower's strategic focus on improving senior housing occupancy and acquisitions aimed at portfolio expansion are designed to drive revenue and NOI growth.Seeking Alpha • Jun 20
Welltower: Trades At A Premium But For Good Reason
Summary Real Estate Investment Trusts have struggled with interest rate hikes, but Welltower has outperformed, with a 31% return since September 2023. Welltower operates a wide portfolio of senior housing and medical facilities, with plans for growth and increased occupancy rates. Financially, Welltower has seen revenue growth, increased investments, and a safe dividend, but trades at a high valuation with potential risks ahead. The low dividend yield of 2.3% leaves a lot to be desired but strong segment growth could contribute to future raises. Read the full article on Seeking AlphaAufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie Welltower Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 26 | 11,767 | 1,408 | 1,752 | 0 |
| 31 Dec 25 | 10,838 | 937 | 1,748 | 0 |
| 30 Sep 25 | 9,908 | 960 | 240 | 0 |
| 30 Jun 25 | 9,278 | 1,130 | 255 | 0 |
| 31 Mar 25 | 8,554 | 1,082 | 246 | 0 |
| 31 Dec 24 | 7,991 | 952 | 235 | 0 |
| 30 Sep 24 | 7,490 | 916 | 231 | 0 |
| 30 Jun 24 | 7,031 | 593 | 199 | 0 |
| 31 Mar 24 | 6,872 | 442 | 188 | 0 |
| 31 Dec 23 | 6,573 | 340 | 179 | 0 |
| 30 Sep 23 | 6,283 | 252 | 176 | 0 |
| 30 Jun 23 | 6,160 | 118 | 165 | 0 |
| 31 Mar 23 | 5,973 | 105 | 157 | 0 |
| 31 Dec 22 | 5,861 | 141 | 150 | 0 |
| 30 Sep 22 | 5,619 | 204 | 142 | 0 |
| 30 Jun 22 | 5,385 | 390 | 140 | 0 |
| 31 Mar 22 | 5,053 | 327 | 135 | 0 |
| 31 Dec 21 | 4,737 | 336 | 127 | 0 |
| 30 Sep 21 | 4,555 | 441 | 121 | 0 |
| 30 Jun 21 | 4,352 | 587 | 120 | 0 |
| 31 Mar 21 | 4,393 | 740 | 123 | 0 |
| 31 Dec 20 | 4,587 | 979 | 128 | 0 |
| 30 Sep 20 | 4,747 | 1,039 | 127 | 0 |
| 30 Jun 20 | 4,976 | 1,304 | 127 | 0 |
| 31 Mar 20 | 5,108 | 1,262 | 127 | 0 |
| 31 Dec 19 | 5,121 | 1,232 | 127 | 0 |
| 30 Sep 19 | 5,100 | 1,110 | 131 | 0 |
| 30 Jun 19 | 5,070 | 584 | 129 | 0 |
| 31 Mar 19 | 4,865 | 601 | 128 | 0 |
| 31 Dec 18 | 4,700 | 758 | 126 | 0 |
| 30 Sep 18 | 4,553 | 545 | 124 | 0 |
| 30 Jun 18 | 4,408 | 555 | 125 | 0 |
| 31 Mar 18 | 4,351 | 589 | 125 | 0 |
| 31 Dec 17 | 4,317 | 464 | 122 | 0 |
| 30 Sep 17 | 4,291 | 908 | 126 | 0 |
| 30 Jun 17 | 4,278 | 1,169 | 133 | 0 |
| 31 Mar 17 | 4,296 | 1,176 | 141 | 0 |
| 31 Dec 16 | 4,281 | 1,012 | 155 | 0 |
| 30 Sep 16 | 4,232 | 812 | 159 | 0 |
| 30 Jun 16 | 4,132 | 659 | 159 | 0 |
| 31 Mar 16 | 4,013 | 777 | 158 | 0 |
| 31 Dec 15 | 3,860 | 818 | 147 | 0 |
| 30 Sep 15 | 3,698 | 874 | 158 | 0 |
| 30 Jun 15 | 3,567 | 828 | 152 | 0 |
Qualität der Erträge: WELL hat einen großen einmalig Gewinn von $1.7B verbucht, der sich auf die Finanzergebnisse der letzten 12 Monate bis zum 31st March, 2026 auswirkt.
Wachsende Gewinnspanne: WELLDie aktuellen Gewinnspannen (12%) sind niedriger als im letzten Jahr (12.7%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: WELLIn den letzten 5 Jahren sind die Einnahmen von 28.1% pro Jahr erheblich gestiegen.
Beschleunigtes Wachstum: WELLDas Gewinnwachstum des Unternehmens im letzten Jahr (30%) übertrifft seinen 5-Jahres-Durchschnitt (28.1% pro Jahr).
Erträge im Vergleich zur Industrie: WELL Das Gewinnwachstum im vergangenen Jahr (30%) übertraf das der Branche Health Care REITs 20.5% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: WELLDie Eigenkapitalrendite des Unternehmens (3.2%) wird als niedrig angesehen.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/24 23:24 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Welltower Inc. wird von 46 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| David Rodgers | Baird |
| Amanda Sweitzer | Baird |
| Joshua Raskin | Barclays |